Patient Advocacy Webinar on “The Impact of the EU’s Substances of Human Origin (SOHO) Regulation on Alpha-1 Patients”
Duration: 1:32:26
On 19 February 2024 Alpha-1 Global, in cooperation with Alpha-1 Europe Alliance, organised a webinar, which explored the impact of the EU Substances of Human origin (SoHO) Regulation on the lives of European Alphas. The speakers included:
• Scott Santarella (CEO of Alpha-1 Global)
• Dr. Heinz Stutzenberger, (Vice-President of the board of Alpha-1 Europe alliance)
• Sebastian Rhode, (Founder of RPP)
• Kinga Wojtowicz (Head of Office and Senior Account Director at RPP)
• Anton Stoyanov (Consultant at RPP)
